Better Diagnosis of Acute Heart Failure Using Pronota's Novel Biomarker Wall Street Journal Two independent validation studies demonstrate that Pronota's biomarker CD146 significantly improves the diagnosis of acute heart failure for patients with shortness of breath. The biomarker, measured in blood, provides clinicians with unique ... |
